{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:00:31Z","timestamp":1791000031242,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.vaccine.2011.09.135","type":"journal-article","created":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T17:07:07Z","timestamp":1318871227000},"page":"9684-9690","source":"Crossref","is-referenced-by-count":31,"title":["Attenuated NYCBH vaccinia virus deleted for the E3L gene confers partial protection against lethal monkeypox virus disease in cynomolgus macaques"],"prefix":"10.1016","volume":"29","author":[{"given":"Karen L.","family":"Denzler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahar","family":"Babas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Rippeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trung","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuko","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lowrey","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Silvera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertram L.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"October (1)","key":"10.1016\/j.vaccine.2011.09.135_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2009.06.006","article-title":"Vaccinia virus vaccines: past, present and future","volume":"84","author":"Jacobs","year":"2009","journal-title":"Antiviral Res"},{"issue":"November\u2013December (6)","key":"10.1016\/j.vaccine.2011.09.135_bib0010","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3201\/eid0706.010602","article-title":"Developing new smallpox vaccines","volume":"7","author":"Rosenthal","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.09.135_bib0015","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/13543784.17.4.555","article-title":"ACAM2000: a newly licensed cell culture-based live vaccinia smallpox vaccine","volume":"17","author":"Greenberg","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"issue":"June (23)","key":"10.1016\/j.vaccine.2011.09.135_bib0020","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1016\/j.vaccine.2008.03.044","article-title":"Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: scarification vaccination","volume":"26","author":"Jentarra","year":"2008","journal-title":"Vaccine"},{"issue":"June (2)","key":"10.1016\/j.vaccine.2011.09.135_bib0025","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1006\/viro.1993.1292","article-title":"Identification of a conserved motif that is necessary for binding of the vaccinia virus E3L gene products to double-stranded RNA","volume":"194","author":"Chang","year":"1993","journal-title":"Virology"},{"issue":"February (6)","key":"10.1016\/j.vaccine.2011.09.135_bib0030","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1073\/pnas.0308260100","article-title":"Evidence that vaccinia virulence factor E3L binds to Z-DNA in vivo: implications for development of a therapy for poxvirus infection","volume":"101","author":"Kim","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"October (20)","key":"10.1016\/j.vaccine.2011.09.135_bib0035","doi-asserted-by":"crossref","first-page":"10083","DOI":"10.1128\/JVI.00607-06","article-title":"Suppression of proinflammatory signal transduction and gene expression by the dual nucleic acid binding domains of the vaccinia virus E3L proteins","volume":"80","author":"Langland","year":"2006","journal-title":"J Virol"},{"issue":"July (2)","key":"10.1016\/j.vaccine.2011.09.135_bib0040","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.virol.2004.03.012","article-title":"Inhibition of PKR by vaccinia virus: role of the N- and C-terminal domains of E3L","volume":"324","author":"Langland","year":"2004","journal-title":"Virology"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.09.135_bib0045","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1089\/jir.2009.0073","article-title":"The interferon system and vaccinia virus evasion mechanisms","volume":"29","author":"Perdiguero","year":"2009","journal-title":"J Interferon Cytokine Res"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2011.09.135_bib0050","first-page":"251","article-title":"Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus","volume":"76","author":"Xiang","year":"2002","journal-title":"J Virol"},{"issue":"September (Pt 9)","key":"10.1016\/j.vaccine.2011.09.135_bib0055","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1099\/vir.0.021998-0","article-title":"Inhibition of the RNA polymerase III-mediated dsDNA-sensing pathway of innate immunity by vaccinia virus protein E3","volume":"91","author":"Valentine","year":"2010","journal-title":"J Gen Virol"},{"issue":"September (38)","key":"10.1016\/j.vaccine.2011.09.135_bib0060","doi-asserted-by":"crossref","first-page":"25471","DOI":"10.1074\/jbc.M109.018895","article-title":"The double-stranded RNA binding domain of the vaccinia virus E3L protein inhibits both RNA- and DNA-induced activation of interferon beta","volume":"284","author":"Marq","year":"2009","journal-title":"J Biol Chem"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2011.09.135_bib0065","doi-asserted-by":"crossref","first-page":"6974","DOI":"10.1073\/pnas.0431131100","article-title":"A role for Z-DNA binding in vaccinia virus pathogenesis","volume":"100","author":"Kim","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2011.09.135_bib0070","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1128\/JVI.75.2.850-856.2001","article-title":"Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model","volume":"75","author":"Brandt","year":"2001","journal-title":"J Virol"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2011.09.135_bib0075","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1177\/0300985810372506","article-title":"Establishing efficacy of human products using animals: the US food and drug administration's animal rule","volume":"47","author":"Snoy","year":"2010","journal-title":"Vet Pathol"},{"key":"10.1016\/j.vaccine.2011.09.135_bib0080","doi-asserted-by":"crossref","unstructured":"Denzler KL, Rice AD, MacNeill AL, Fukushima N, Lindsey SF, Wallace G, et al. The NYCBH vaccinia virus deleted for the innate immune evasion gene, E3L, protects rabbits against lethal challenge by rabbitpox virus. doi:10.1016\/j.vaccine.2011.07.140.","DOI":"10.1016\/j.vaccine.2011.07.140"},{"key":"10.1016\/j.vaccine.2011.09.135_bib0210","article-title":"The attenuated NYCBH vaccinia virus deleted for the immune evasion gene, E3L, completely protects mice against heterologous challenge with ectromelia virus","author":"Denzler","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.09.135_bib0085","series-title":"Smallpox and its eradication","author":"Fenner","year":"1988"},{"issue":"July (4)","key":"10.1016\/j.vaccine.2011.09.135_bib0090","doi-asserted-by":"crossref","first-page":"781","DOI":"10.4269\/ajtmh.1985.34.781","article-title":"Human monkeypox: a newly emerged orthopoxvirus zoonosis in the tropical rain forests of Africa","volume":"34","author":"Arita","year":"1985","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.vaccine.2011.09.135_bib0095","first-page":"459","article-title":"Clinico-epidemiological features of monkeypox patients with an animal or human source of infection","volume":"66","author":"Jezek","year":"1988","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2011.09.135_bib0100","series-title":"Human monkeypox. Monographs in virology","author":"Jezek","year":"1988"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2011.09.135_bib0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/jama.290.1.23","article-title":"Monkeypox outbreak a reminder of emerging infections vulnerabilities","volume":"290","author":"Stephenson","year":"2003","journal-title":"JAMA"},{"issue":"January (4)","key":"10.1016\/j.vaccine.2011.09.135_bib0110","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1056\/NEJMoa032299","article-title":"The detection of monkeypox in humans in the Western Hemisphere","volume":"350","author":"Reed","year":"2004","journal-title":"N Engl J Med"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.09.135_bib0115","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1128\/JCM.42.2.601-609.2004","article-title":"Smallpox and pan-orthopox virus detection by real-time 3\u2032-minor groove binder TaqMan assays on the roche LightCycler and the Cepheid smart Cycler platforms","volume":"42","author":"Kulesh","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"March (11\u201312)","key":"10.1016\/j.vaccine.2011.09.135_bib0120","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.vaccine.2003.10.022","article-title":"Mouse neurotoxicity test for vaccinia-based smallpox vaccines","volume":"22","author":"Li","year":"2004","journal-title":"Vaccine"},{"issue":"December (4)","key":"10.1016\/j.vaccine.2011.09.135_bib0125","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1017\/S0022172400037980","article-title":"The antibody response in man following infection with viruses of the pox group. III. Antibody response in smallpox","volume":"56","author":"Downie","year":"1958","journal-title":"J Hyg (Lond)"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2011.09.135_bib0130","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4269\/ajtmh.1972.21.214","article-title":"A prospective study of serum antibody and protection against smallpox","volume":"21","author":"Mack","year":"1972","journal-title":"Am J Trop Med Hyg"},{"issue":"July (13)","key":"10.1016\/j.vaccine.2011.09.135_bib0135","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1128\/JVI.00116-06","article-title":"Obligatory requirement for antibody in recovery from a primary poxvirus infection","volume":"80","author":"Chaudhri","year":"2006","journal-title":"J Virol"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2011.09.135_bib0140","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/infdis\/jiq162","article-title":"Smallpox vaccine safety is dependent on T cells and not B cells","volume":"203","author":"Gordon","year":"2011","journal-title":"J Infect Dis"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2011.09.135_bib0145","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1128\/JVI.80.2.985-998.2006","article-title":"Host response to the attenuated poxvirus vector NYVAC: upregulation of apoptotic genes and NF-kappaB-responsive genes in infected HeLa cells","volume":"80","author":"Guerra","year":"2006","journal-title":"J Virol"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2011.09.135_bib0150","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1128\/JVI.02108-05","article-title":"Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L gene","volume":"80","author":"Najera","year":"2006","journal-title":"J Virol"},{"issue":"May (Pt 5)","key":"10.1016\/j.vaccine.2011.09.135_bib0155","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1099\/vir.0.81623-0","article-title":"Double-stranded RNA-binding protein E3 controls translation of viral intermediate RNA, marking an essential step in the life cycle of modified vaccinia virus Ankara","volume":"87","author":"Ludwig","year":"2006","journal-title":"J Gen Virol"},{"issue":"August (16)","key":"10.1016\/j.vaccine.2011.09.135_bib0160","doi-asserted-by":"crossref","first-page":"8318","DOI":"10.1128\/JVI.76.16.8318-8334.2002","article-title":"The block in assembly of modified vaccinia virus Ankara in HeLa cells reveals new insights into vaccinia virus morphogenesis","volume":"76","author":"Sancho","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.09.135_bib0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025674","article-title":"Improved NYVAC-based vaccine vectors","author":"Kibler","year":"2011","journal-title":"PLoS One"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.09.135_bib0165","doi-asserted-by":"crossref","first-page":"e1000480","DOI":"10.1371\/journal.ppat.1000480","article-title":"Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome","volume":"5","author":"Delaloye","year":"2009","journal-title":"PLoS Pathog"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2011.09.135_bib0170","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1128\/JVI.02345-08","article-title":"Comparison of human and rhesus macaque T-cell responses elicited by boosting with NYVAC encoding human immunodeficiency virus type 1 clade C immunogens","volume":"83","author":"Mooij","year":"2009","journal-title":"J Virol"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2011.09.135_bib0175","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1128\/JVI.02216-07","article-title":"Differential CD4+ versus CD8+ T-cell responses elicited by different poxvirus-based human immunodeficiency virus type 1 vaccine candidates provide comparable efficacies in primates","volume":"82","author":"Mooij","year":"2008","journal-title":"J Virol"},{"issue":"December (1)","key":"10.1016\/j.vaccine.2011.09.135_bib0180","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1006\/viro.2002.1722","article-title":"Equivalent immunogenicity of the highly attenuated poxvirus-based ALVAC-SIV and NYVAC-SIV vaccine candidates in SIVmac251-infected macaques","volume":"304","author":"Hel","year":"2002","journal-title":"Virology"},{"issue":"March (6979)","key":"10.1016\/j.vaccine.2011.09.135_bib0185","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"issue":"September (1)","key":"10.1016\/j.vaccine.2011.09.135_bib0190","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.virol.2007.04.010","article-title":"DNA\/MVA HIV-1\/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge","volume":"366","author":"Nigam","year":"2007","journal-title":"Virology"},{"issue":"August (31)","key":"10.1016\/j.vaccine.2011.09.135_bib0195","doi-asserted-by":"crossref","first-page":"10889","DOI":"10.1073\/pnas.0804985105","article-title":"Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus","volume":"105","author":"Earl","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2011.09.135_bib0200","doi-asserted-by":"crossref","first-page":"7845","DOI":"10.1128\/JVI.79.12.7845-7851.2005","article-title":"Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus","volume":"79","author":"Stittelaar","year":"2005","journal-title":"J Virol"},{"issue":"December (52)","key":"10.1016\/j.vaccine.2011.09.135_bib0205","doi-asserted-by":"crossref","first-page":"8807","DOI":"10.1016\/j.vaccine.2007.10.040","article-title":"Genomic differences of vaccinia virus clones from Dryvax smallpox vaccine: the Dryvax-like ACAM2000 and the mouse neurovirulent Clone-3","volume":"25","author":"Osborne","year":"2007","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11015921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11015921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T10:48:03Z","timestamp":1639219683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11015921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":43,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0264410X11015921"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.09.135","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}